|
|
Dr. James Ingle of Mayo Clinic was the lead U.S. researcher on the study of a new breast cancer drug. The drug, called letrozole, has proven effective in preventing cancer from reoccuring. The study was halted early because of the dramatic results. |
| ©2009 Minnesota Public Radio : Terms of Use |